- Category: News
- Published on Thursday, 03 March 2011 08:23
- Written by Lara Landis
- Hits: 774
The Sex Files column of the Toronto Sun recently questioned the reality of Female Sexual Dysfunction. Pharmaceutical companies raced to create a female equivalent of Viagra after Pfizer released the drug. Pfizer entered into a multi-billion dollar market. Drug companies, hoping to capitalize on the first Viagra's success have attempted to create a female equivalent. Biosante's gel product Lbigel and Apricus's Femprox are leading contenders in the race for a female sexual dysfunction drug.
Sexytypewriter's column questions whether the problem the drug companies want to solve is physical or psychological and only hints slightly that the drug companies may have created a problem in order to solve a proposed solution. "Sexual dysfunction in the United States: prevalence and predictors”, an article published in the Journal of the American Medical Association. The authors of the article, two of whom had ties to Pfizer, according to the Sun, estimated the condition occurred in 43% of women between the ages of 18 and 59.
The columnist does acknowledge the difference between physical causes for female sexual dysfunction and psychological causes, but the author does not mention the existence of Asexuality at any point in the article. She does not cover Asexuality as a possible cause for the absence of such fantasies, but does point out that most problems in women stem from issues within a relationship.